Menopause at midlife: what women 45+ should know now

AARP’s new guide to menopause and midlife health arrives at a moment when many women are looking for clearer, more practical information about what changes are normal, what deserves medical attention, and which treatments actually have evidence behind them. For adults 45 and older, menopause is not just a reproductive milestone; it can overlap with sleep problems, hot flashes, vaginal symptoms, mood changes, and shifts in long-term heart and bone health. https://www.aarp.org/states/ohio/your-expert-guide-to-menopause-and-midlife-health/

The key takeaway from current medical guidance is that menopause is a normal stage of life, not a disease. But the transition around it can affect day-to-day comfort and long-term risk in ways that are worth understanding. https://www.nia.nih.gov/health/menopause/what-menopause?_sp=c1bfbfa7-571b-4b8a-bc17-1e80f60b95c5

What the AARP story is highlighting

The AARP piece, published October 6, 2026, is framed as a practical guide for navigating menopause and the broader midlife years. Its timing is notable because menopause-related questions often become more urgent in the late 40s and 50s, when symptoms may intensify, periods become less predictable, and women start thinking more seriously about heart, bone, sleep, and sexual health. https://www.aarp.org/states/ohio/your-expert-guide-to-menopause-and-midlife-health/

That focus aligns with public-health guidance from the National Institute on Aging and NIH, which describe the menopausal transition, or perimenopause, as the years leading up to the final menstrual period. Symptoms can include hot flashes, night sweats, trouble sleeping, moodiness, irritability, forgetfulness, difficulty concentrating, joint or muscle discomfort, and pain during sex. https://www.nia.nih.gov/health/menopause/what-menopause?_sp=c1bfbfa7-571b-4b8a-bc17-1e80f60b95c5

Why it matters after 45

For many women, the midlife years are when menopause symptoms first start to disrupt routine life. Some people have only mild changes; others deal with sleep loss, urinary or vaginal discomfort, or hot flashes that interfere with work and daily activities. The NIA notes that symptoms vary widely, and some women have few or none. https://www.nia.nih.gov/health/menopause/what-menopause?_sp=c1bfbfa7-571b-4b8a-bc17-1e80f60b95c5

Midlife is also a time to pay attention to cardiovascular risk. The American Heart Association says a woman’s risk for heart disease and stroke increases at and around menopause, and recent reviews in PubMed describe the menopausal transition as a period when blood pressure, body composition, lipids, and insulin resistance may worsen. That does not mean menopause alone causes heart disease, but it does appear to be a useful checkpoint for prevention. https://www.heart.org/en/health-topics/house-calls/menopause-and-heart-health

Bone health matters too. FDA and NIH materials note that the drop in estrogen after menopause can affect bone density, which is one reason clinicians often revisit osteoporosis screening and prevention as women age. https://www.fda.gov/consumers/womens-health-topics/menopause

What the evidence actually shows

Hormone therapy can be effective for relieving bothersome hot flashes, night sweats, and vaginal dryness, and the FDA says it may also help reduce the risk of osteoporosis in some women. At the same time, it is not appropriate for everyone. FDA guidance says women with a history of breast cancer, stroke, heart attack, blood clots, liver disease, or unexplained vaginal bleeding should not use menopausal hormone therapy without careful medical review. https://www.fda.gov/consumers/womens-health-topics/menopause

In February 2026, the FDA approved labeling changes for several menopausal hormone therapy products. The agency removed boxed-warning language that had specifically listed cardiovascular disease, breast cancer, and probable dementia for those products, saying the update was intended to better reflect current evidence and support informed decisions. That does not mean the therapies are risk-free; it means the risk discussion has been revised. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products

NIH and FDA sources also caution that so-called compounded or “bioidentical” hormone products are not proven safer or more effective than FDA-approved options. The safest approach, according to FDA, is to use therapies that are approved and discussed with a clinician who can weigh benefits and risks for the individual patient. https://www.fda.gov/consumers/womens-health-topics/menopause

For vaginal dryness and pain with sex, NIH notes that FDA has approved two nonhormonal medicines, ospemifene and prasterone, for moderate to severe symptoms. That matters because some women want relief but are not candidates for systemic hormone therapy. https://health.nih.gov/womens-health/menopause

What remains uncertain

Some menopause advice online can sound more definitive than the science really is. The current evidence supports symptom relief for specific treatments, but it does not prove that any single approach is best for every woman in midlife. Risks also vary by age, time since menopause, personal history, and the form or route of treatment used. https://www.fda.gov/consumers/womens-health-topics/menopause

Researchers continue to study how much of the heart-health change seen around menopause is driven by ovarian aging itself versus aging more broadly. The best-supported conclusion is that the menopausal transition is a useful time to reassess blood pressure, cholesterol, glucose, weight, activity, sleep, and other risk factors. https://pubmed.ncbi.nlm.nih.gov/38555760/

What to discuss with a clinician

For women 45 and older who are having symptoms, a useful conversation with a clinician often includes three questions: whether the symptoms fit the menopausal transition, whether any treatment is appropriate, and whether other conditions could be contributing. That is especially important if symptoms are severe, start very early, or interfere with sleep, work, sex, or mood. https://www.nia.nih.gov/health/menopause/what-menopause?_sp=c1bfbfa7-571b-4b8a-bc17-1e80f60b95c5

Heavy or very frequent bleeding is not something to dismiss as “just menopause.” NIH says women with very heavy bleeding or periods close together should talk with a health care professional. Likewise, new chest pain, shortness of breath, fainting, or stroke-like symptoms are urgent and require immediate care. https://health.nih.gov/womens-health/menopause

For many adults in midlife, the most practical next step is not chasing a miracle fix. It is getting a clear diagnosis, reviewing heart and bone risk, and matching treatment to symptoms and medical history. That is the kind of grounded, evidence-based approach AARP’s new guide is aiming to encourage. https://www.aarp.org/states/ohio/your-expert-guide-to-menopause-and-midlife-health/

This article is for general information only and is not a substitute for medical advice, diagnosis, or treatment.

Next article → Testosterone therapy and heart safety: what women should know